ArticleBMC sports science, medicine & rehabilitation2026
Expression and mechanism of TRPV1 channel in prefrontal cortex after acute hypoxic exercise.
Article in BMC sports science, medicine & rehabilitation, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveThis study investigates the role of transient receptor potential vanilloid subtype 1 (TRPV1) in acute hypoxic exercise.
methodsAfter acute hypoxia intervention, the mRNA expression levels of TRPV1 and 5-hydroxytryptamine 1 A (5-HT1A) in the prefrontal cortex of rats were detected by real-time quantitative polymerase chain reaction (RT-PCR). Meanwhile, the content of 5-hydroxytryptamine (5-HT) in this area was determined by enzyme-linked immunosorbent assay (ELISA).
resultsHypoxic conditions significantly reduced the duration of high-load exercise performance in rats, resulting in an earlier onset of fatigue and a pronounced decline in exercise capacity (p < 0.05). Acute hypoxic exercise upregulated the expression of TRPV1, 5-HT, and 5-HT1A in the prefrontal cortex (p < 0.05), which may lead to a decrease in exercise capacity. Pharmacological blockade of TRPV1 and 5-HT1A receptors extended the duration of high-load exercise under hypoxic conditions and improved exercise capacity (p < 0.05).
conclusionOur findings indicate that the upregulation of TRPV1, 5-HT, and 5-HT1A is a key mechanism underlying the decline in exercise performance during acute hypoxia. Pharmacological blockade of these pathways effectively alleviates hypoxia-induced exercise fatigue, suggesting they represent promising therapeutic targets for enhancing performance under hypoxic conditions. SIGNIFICANCE: These findings provide a biological basis for developing nutritional strategies to counteract the initial decline in physical performance experienced by military personnel and adventurers during their ascent to high-altitude environments.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.